To stent or not to stent? We present 3 studies with opposing responses to this question.
Mark L. Fuerst
Several new studies feature developments in remyelination in MS. Oligodendrocyte precursor cells may be a promising target for MS treatments, and microRNA expression are perhaps an attractive MS biomarker.
Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.
This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.
A skin test used to detect elevated levels of abnormal proteins may allow earlier diagnosis of Alzheimer and Parkinson diseases, according to a new study.
A non-psychoactive component of the marijuana plant, cannabidiol in liquid form decreased seizures by an average of 50% across multiple types of severe epilepsy.
Highlights of recent findings about multiple sclerosis are summarized in this slide show.
Some patients who take aspirin have the potential for larger, more severe strokes. Highlights of the latest news about stroke are presented in this slide show.
Minimally invasive surgery to remove clots from the brain and other cutting-edge stroke news for neurologists highlighted the research and clinical program at the International Stroke Conference.
This treatment may be superior to current treatment for patients with severe multiple sclerosis that is not responding well to standard treatments.